Stock-Based Compensation Expense (Tables)

12 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The total grants awarded during the period from June 4, 2018 through December 31, 2018 are presented in the table below:

	Successor Company
	Period from June 4, 2018 through December 31, 2018
	Grants	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Weighted Average Grant Date Fair Value
Stock option grants	581,124	$	25.47	4.4	$	7.60
Restricted stock unit grants	600,031	Not Applicable		4.4	$	15.00
Total grants in the successor period	1,181,155

The total grants awarded during the Period from January 1, 2018 through June 4, 2018 period, and the year ended December 31, 2017 are presented in the table below:    

	Predecessor Company
		Period from January 1, 2018 through June 3, 2018	Year Ended December 31, 2017	Year Ended December 31, 2016
Stock option grants *		—	76,250	389,938

The total share-based compensation expense included in “Corporate expenses” in the accompanying Consolidated Statements of Operations for the period from January 1, 2018 through June 3, 2018 and the years ended December 31, 2017 and 2016 was as follows (in thousands):

	Predecessor Company
		Period from January 1, 2018 through June 3, 2018			Year Ended December 31, 2017		Year Ended December 31, 2016
Stock option grants			$	231	$	1,614	$	2,948

The total share-based compensation expense included in “Corporate expenses” in the accompanying Consolidated Statements of Operations for the period from June 4, 2018 through December 31, 2018 was as follows (in thousands):

	Successor Company
	Period from June 4, 2018 through December 31, 2018
Stock option grants		$	853
Restricted stock unit grants	2,551
Total expense		$	3,404